SLC16A1 and urinary bladder carcinoma: These data demonstrate that E2F1-mediated activation of the SLC16A1-AS1/MCT1 gene pair favors metabolic plasticity and reprogramming of bladder cancer cells, thereby facilitating cancer progression to invasive stages.